Aldeyra Therapeutics (ALDX) Misses Q2 EPS by 4c

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($0.28), $0.04 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Is the global equity rally broadening? UBS weighs in
• BMO starts chip stocks coverage: Here are its preferred picks